Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 2;11(15):5613-5627.
doi: 10.18632/aging.102142. Epub 2019 Aug 2.

Androgen deprivation therapy increases brain ageing

Affiliations

Androgen deprivation therapy increases brain ageing

Julio Plata-Bello et al. Aging (Albany NY). .

Abstract

Background: Prostate cancer (PC) is the most frequent neoplasia in the male population and androgen deprivation therapy (ADT) is frequently used in the management of the disease.

Aim: To evaluate the effect of ADT exposure on cognitive status, grey matter volume (GMV) and white matter lesion (WML) load.

Methods: Fifty ADT patients and fifteen PC-non-ADT (control) patients were included in the study. A neuropsychological evaluation was performed and a magnetic resonance imaging (MRI), with anatomical T1 and FLAIR sequences, was performed to evaluate the GMV and the WML burden.

Results: Most of the patients included in the study presented a significant cognitive impairment (CI). No significant differences were identified in the cognitive assessment between the studied groups, but when considering the educational background intragroup differences were found.No significant difference of GMV and WML volume were identified between groups, but a negative relationship between the ADT period and the GMV was identified. Furthermore, a significant positive association between the age and the lesion volume was found in the ADT group (β=.406; p=.004).

Conclusion: PC patients exposed to ADT present an acceleration of age-related brain changes, such as WML development and GMV loss.

Keywords: androgen deprivation therapy; cognitive impairment; grey matter volume; prostate cancer; white matter lesion.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: All authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Association of ADT period and MRI findings. (A) Positive relationship between the ADT period (months) and lesion volume (no statistical significance); (B) negative relationship between the ADT period (months) and the grey matter volume (statistically significant; p<.05).
Figure 2
Figure 2
Regression analysis between age and lesion volume (A) and between the age and grey matter volume (B).

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019; 69:7–34. 10.3322/caac.21551 - DOI - PubMed
    1. Helgstrand JT, Røder MA, Klemann N, Toft BG, Brasso K, Vainer B, Iversen P. Diagnostic characteristics of lethal prostate cancer. Eur J Cancer. 2017; 84:18–26. 10.1016/j.ejca.2017.07.007 - DOI - PubMed
    1. Huggins C, Hodges CV. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol. 2002; 168:9–12. 10.1016/S0022-5347(05)64820-3 - DOI - PubMed
    1. EAU-ESTRO-ESUR-SIOG Prostate Cancer Guidelines Panel. Prostate Cancer and the John West Effect. Eur Urol. 2017; 72:7–9. 10.1016/j.eururo.2017.02.006 - DOI - PubMed
    1. Sharifi N, Gulley JL, Dahut WL. Androgen deprivation therapy for prostate cancer. JAMA. 2005; 294:238–44. 10.1001/jama.294.2.238 - DOI - PubMed

MeSH terms

Substances